Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger EM, Kandioler D, Berger W, Stiglbauer W, Depisch D, Pirker R, Zielinski CC, Zöchbauer-Müller S.
Heller G, et al. Among authors: filipits m.
Breast Cancer Res Treat. 2007 Jul;103(3):283-91. doi: 10.1007/s10549-006-9377-7. Epub 2007 Jan 27.
Breast Cancer Res Treat. 2007.
PMID: 17260099